Clinical Trial Update: Extension to a Pivotal Study of Sensory Stimulation in Alzheimer's Disease (OLE Hope Study, CA-0015) [NA]

View source ↗

Summary

Clinical update announcing an extension to Cognito Therapeutics' pivotal sensory stimulation study in Alzheimer's disease, with enrollment by invitation ongoing…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Alzheimer Disease
• Cognitive Impairment
• Dementia

Snippet

Sponsor: Cognito Therapeutics, Inc. | Conditions: Alzheimer Disease, Cognitive Impairment | NA | Status: ENROLLING_BY_INVITATION